Skip to main content
The Globe and Mail
Support Quality Journalism
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); }

Cannabis Professional’s daily roundup of industry news. View archive here.

Piper Sandler cuts price to target on Aurora to $1

Investment bank Piper Sandler cut its price target for Aurora Cannabis Inc. to $1 from $3, citing expectations that the company will have negative cash flow from operations until the second half of 2021. Moreover, analyst Michael Lavery expects Aurora will have a short term deficit of $200-million, which “may prove difficult to finance in this capital environment.”

“We project it would also still have to refinance its C$360M of debt due August 2021, after which we project it could have over C$800M in debt and C$30M cash in F2Q22 (which would be about a third of its accounts payable balance),” Mr. Lavery wrote.

Story continues below advertisement

Hopes that underperformance in the Canadian market will be offset by exports to Europe have been hampered by Aurora’s sales being halted in Germany, Mr. Lavery wrote.

“Aurora expects to re-start medical sales in Germany in early 2020, but we have little visibility on this process and government agencies can be notoriously slow. The temporary sales halt could have a lasting impact in the German medical cannabis market, as doctors tend to prescribe products that have strong track records of availability,” he wrote.

– Mark Rendell

MediPharm ships first white label Cannabis 2.0 products

MediPharm Labs Corp. said on Thursday that it has shipped its first white label Cannabis 2.0 products to provincial wholesalers. The shipment was made in partnership with a B.C. numbered company that does business under the name Shelter Brand House.

The 12-month white label agreement will see MediPharm fill and ship vape cartridges for Shelter. The first cartridges were shipped in December under the brand ‘Wayfarer’ to British Columbia., Saskatchewan and Manitoba.

“Under the Agreement, MediPharm Labs will receive certain fees for services related to procurement, formulation, quality assurance, manufacturing and distributing to provincial retailers, along with a portion of revenue from sales of the Shelter vape cartridges,” the company said in a news release.

- Mark Rendell

Story continues below advertisement

Recently, around the industry:

Follow related topics

Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies